v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 154,490 $ 176,498
Prepaid expenses and other current assets 2,495 2,246
Total current assets 156,985 178,744
Property and equipment, net 122 91
Other assets 698 698
Total assets 157,805 179,533
Current liabilities    
Accounts payable and accrued expenses 18,696 19,514
Total current liabilities 18,696 19,514
Total liabilities 18,696 19,514
Commitments and contingencies (Note 9)
Redeemable noncontrolling interest 11,663 11,663
Shareholders' Equity    
Preferred shares, $0.0001 par value, 1,000,000 shares authorized as of June 30, 2025 and December 31, 2024; no shares issued and outstanding as of June 30, 2025 and December 31, 2024
Class A Ordinary Shares, $0.0001 par value; 300,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 62,064,270 and 65,297,530 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 6 7
Additional paid-in capital 315,231 302,705
Accumulated deficit (189,332) (155,897)
Total Zura Bio Limited shareholders' equity 125,905 146,815
Noncontrolling interest 1,541 1,541
Total shareholders' equity 127,446 148,356
Total liabilities, redeemable noncontrolling interest and shareholders' equity $ 157,805 $ 179,533